P3H2
P3H2 (prolyl 3-hydroxylase 2, also known as LEPREL1, MLAT4 and FLJ10718) is a leprecan-family enzyme that catalyses the post-translational formation of 3-hydroxyproline on collagens. It belongs to the iron (II) and 2-oxoglutarate dependent oxygenases. Browse Assay Genie's current range of P3H2 research reagents below, or read on for the biology behind the target.
P3H2 is a prolyl 3-hydroxylase that catalyses the formation of 3-hydroxyproline on collagens. It hydroxylates the first proline in Gly-Pro-Hyp sequences, where Hyp is 4-hydroxyproline, and it has no activity on substrates that lack 4-hydroxyproline in the third position. Activity is highest on type IV collagen (COL4A1) and lower on COL1A1. The enzyme contributes to proline 3-hydroxylation of these collagens in tendons, the eye sclera and the eye lens capsule.
The P3H2 gene encodes a member of the prolyl 3-hydroxylase subfamily of 2-oxoglutarate-dependent dioxygenases, and the protein belongs to the leprecan family. UniProt records it in the endoplasmic reticulum, sarcoplasmic reticulum and Golgi apparatus. These enzymes play a critical role in collagen chain assembly, stability and cross-linking through 3-hydroxylation of proline residues. Alternatively spliced transcript variants encoding multiple isoforms have been observed. Mouse and rat orthologs are both designated P3h2, which allows comparative work in rodent models.
The gene was formerly named leprecan-like 1 (LEPREL1), and MLAT4 and FLJ10718 are also used as aliases. Mutations in P3H2 are associated with nonsyndromic severe myopia with cataract and vitreoretinal degeneration. Downregulation of the gene may also play a role in breast cancer. Researchers studying P3H2 often work on collagen biochemistry, basement membrane biology and ocular disease, using P3H2 antibody, P3H2 ELISA kit or recombinant P3H2 protein reagents to examine expression and function.
P3H2 catalyses 3-hydroxylation of proline in collagens, a modification important for collagen chain assembly, stability and cross-linking.
The enzyme shows high activity on type IV collagen COL4A1, making it relevant to studies of type IV collagen modification.
P3H2 mutations are associated with nonsyndromic severe myopia with cataract and vitreoretinal degeneration, and the enzyme acts in sclera and lens capsule.
Downregulation of the P3H2 gene may play a role in breast cancer, prompting studies of its expression in tumours.
P3H2 is a prolyl 3-hydroxylase that forms 3-hydroxyproline on collagens. It acts on the first proline of Gly-Pro-Hyp sequences, needs 4-hydroxyproline in the third position, and is more active on COL4A1 than on COL1A1. It contributes to modification of collagen in tendons, sclera and lens capsule.
P3H2 was previously named leprecan-like 1, with the symbol LEPREL1. MLAT4 and FLJ10718 are further aliases. The protein is also called prolyl 3-hydroxylase 2. NCBI notes that alternative splicing produces transcript variants encoding multiple isoforms.
Mutations in P3H2 are associated with nonsyndromic severe myopia with cataract and vitreoretinal degeneration, and its downregulation may play a role in breast cancer. Mouse and rat both carry a P3h2 ortholog; check the datasheet of any product for its validated reactivity.
Other prolyl 3-hydroxylases, collagen substrates and collagen-modification partners with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8IVL5; product specifications from Assay Genie datasheets.